Before you sign or pay
- Court record: 1 federal case name Femasys Inc. under its legal name in its state; the latest is Femasys, Inc. v. Norgenix Pharmaceuticals, LLC, filed 2015-04-07.
- Bankruptcy: no bankruptcy or receivership report found under FEMASYS INC in our SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Empery Asset Management, LP (filed 2026-10-15).
Who is behind it
Femasys Inc.: incorporated in Delaware; business address in Suwanee, Georgia; industry Surgical & Medical Instruments & Apparatus (Schedule 13G, 2026-10-15).
Officers and directors, each with the role and the filing that names them:
- Kathy Lee-Sepsick: Executive Officer, Director (Form D, 2026-08-20)
- Dov Elefant: Executive Officer (Form D, 2026-08-20)
- Charles Larsen: Director (Form D, 2026-08-20)
- Alistair Milnes: Director (Form D, 2026-08-20)
- Kenneth Eichenbaum: Director (Form D, 2026-08-20)
- Edward R. Uzialko: Director (Form D, 2026-08-20)
- Jeremy Sippos: Executive Officer (Form D, 2026-08-20)
- John Canninng: Executive Officer (Form D, 2026-08-20)
- Jeffrey Mifek: Executive Officer (Form D, 2026-08-20)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-15 | Empery Asset Management, LP | 5.6% |
| Schedule 13G, 2026-08-31 | Stonepine Capital Management, LLC | 7.2% |
| Schedule 13D, 2026-08-17 | Nantahala Capital Partners Limited Partnership | 9.99% |
| Schedule 13G, 2026-08-14 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G, 2026-03-18 | Pharmacyte Biotech, Inc. | 7.87% |
| Schedule 13G/A, 2025-11-14 | Dauntless Investment Group, LLC | 9.9% |
| Schedule 13G, 2025-09-04 | Alumni Capital LP | 9.99% |
| Schedule 13G/A, 2025-08-05 | Chernett Jorey | 9.3% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-08-20 | $30M | $30M |
| Form D, 2025-11-14 | $8.03M | $12M |
| Form D, 2025-06-10 | $1.45M | $1.45M |
| Form D, 2023-11-22 | $6.85M | $6.85M |
Latest IPO step: Femasys Inc. amended its IPO registration (S-1/A, 2025-08-21).
IPO filings: S-1/A, 2025-08-21, S-1, 2025-08-20; ticker FEMY on Nasdaq Capital Market.
Court and legal record
| Case | Court | Filed | Status |
|---|---|---|---|
| Femasys, Inc. v. Norgenix Pharmaceuticals, LLC | District Court, N.D. Georgia | 2015-04-07 | closed 2015-06-05 |
A docket records that a case was brought, not that anything in it is true.
Related pages
Funding and filing history5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/femasys-incLast updated 2026-10-18
Primary record: Schedule 13G, 2026-10-15 · Form D, 2026-08-20 · Docket, Femasys, Inc. v. Norgenix Pharmaceuticals, LLC · S-1/A, 2025-08-21
Who owns Femasys Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/femasys-inc